Osilodrostat and Treatment of Cushing's Disease
Oct 30, 2020, 03:56 PM
Dr. Georgiana Dobri, a neuroendocrinologist with Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.
We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.
Please check your internet connection and refresh the page. You might also try disabling any ad blockers.
You can visit our support center if you're having problems.